期刊文献+

前列腺增生患者电切术发生电切综合征的危险因素分析 被引量:3

Analysis on the Risk Factors of Postoperative Transurethral Resection Syndrome in Patients with Prostatic Hyperplasia
下载PDF
导出
摘要 目的探讨前列腺增生患者行经尿道电切术后发生电切综合征的相关危险因素。方法以我科接受经尿道前列腺电切治疗的335例良性前列腺增生患者为研究对象,分析电切综合征的发生概率及相关危险因素。结果电切综合征的危险因素依次为切除前列腺重量≥30 g、手术欠熟练、合并慢性基础疾病、手术时间≥90 min、术中需输血、膀胱或前列腺包膜穿孔,对高危者进行预防处理可防止电切综合征的发生。结论对于手术时间长、切除体积大、术中需输血、出现包膜穿孔或合并慢性基础疾病者,应密切观察,防止电切综合征的发生;而增强手术熟练程度及进行积极的预防处理,可减少其发生。 Objective To explore the related risk factors of transurethral resection syndrome(TURS) after transurethral resection of the prostate(TURP) in patients with prostatic hyperplasia.Methods 335 benign prostatic hyperplasia patients with TURP in our department were selected as the research objects to analyze the incidence of TURS and its related risk factors.Results The risk factors of TURS were as followed: the weight of resected prostate tissue ≥30 g,inexperienced operative skills,complicated with basic chronic illness,operation time ≥90 min,operative blood transfusion,and perforation of bladder or prostate capsule.Preventive treatment for patients with high risk could prevent the occurrence of TURS.Conclusions Patients with long operation time,large size of resected,operative blood transfusion,perforation of capsule or complicated with basic chronic illness should be observed carefully to prevent the occurrence of TURS.The strengthened operative skill level and positive treatment for complications can reduce the incidence of TURS.
作者 康灵斌
出处 《临床医学工程》 2013年第9期1117-1118,共2页 Clinical Medicine & Engineering
关键词 经尿道前列腺电切 前列腺增生 危险因素 多因素分析 Transurethral resection of the prostate Prostatic hyperplasia Risk factors Multivariate analysis
  • 相关文献

参考文献6

二级参考文献46

共引文献80

同被引文献37

  • 1张祥华,王行环,王刚,魏强,许传亮,薛蔚,严维刚,杨家荣,朱刚,孙颖浩,叶章群,孙则禹,那彦群.良性前列腺增生临床诊治指南[J].中华外科杂志,2007,45(24):1704-1707. 被引量:220
  • 2Gacci M,Corona G,Salvi M,et al.A systematic review and metaanalysis on the use of phosphodiesterase 5 inhibitors alone or in combination withα-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia.Eur Urol,2012,61(5):994-1003.
  • 3Shrivastava A,Gupta VB.Various treatment options for benign prostatic hyperplasia:A current update.J Midlife Health,2012,3(1):10-19.
  • 4Kaplan SA,Chung DE,Lee RK,et al.A 5-year retrospective analysis of 5α-reductase inhibitors in men with benign prostatic hyperplasia:finasteride has comparable urinary symptom efficacy and prostate volume reduction.but less sexual side effects and breast complications than dutasteride.Int J Clin Pract,2012,66(11):1052-1055.
  • 5Kumar A,Vasudcva P, Kumar N, et al. A prospective randomized comparative study of monopolar and bipolar transurethral resection of the prostatcand photosclectivc vaporization of the prostate in pa- tients who present with benign prostatic obstruction ; asingle center experience[J]. 2013,27(10) :1245 - 1253.
  • 6Kranzbtihler B, Wettstein MS, Fankhauser CD, et al. Pure bipo- lar plasma vaporization of the prostate : the Ztirich experience [ J ]. J Endourol, 2013, 27(10) : 1261 -1266.
  • 7Lv L, Wang L, Fan M, et al. Two - year outcome of high - risk be- nign prostate hyperplasia patients treated with transurethral prostate resection by plasmakinetic or conventional procedure [J] . Urolo- gy ,2012,80 (2) :389 - 395.
  • 8Alschibaja M, Mar F, Freiber U, et al. Recent improuvements in transurethral high -frequency electrosurgery of the prostate[ J]. B J Uint ,2014, (97) :243 - 246.
  • 9陈鸿杰,陈一戎.度他雄胺治疗良性前列腺增生的研究进展[J].中华男科学杂志,2011,17(1):63-67. 被引量:12
  • 10李浩勇,胡波,刘继红.良性前列腺增生的药物治疗[J].医药导报,2011,30(1):41-45. 被引量:20

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部